|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
133 a.a.
|
 |
|
|
|
|
|
|
|
134 a.a.
|
 |
|
|
|
|
|
|
|
131 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system
|
 |
|
Title:
|
 |
Crystallographic structure of human c1q globular heads complexed to phosphatidyl-serine
|
|
Structure:
|
 |
Complement c1q subcomponent subunit a. Chain: a, d. Fragment: c-terminal globular region, residues 112-245. Synonym: c1q chain a. Complement c1q subcomponent subunit b. Chain: b, e. Fragment: c terminal globular domain, residues 116-251. Synonym: c1q chain b. Complement c1q subcomponent subunit c.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Synthetic: yes. Organism_taxid: 9606
|
|
Resolution:
|
 |
|
2.05Å
|
R-factor:
|
0.184
|
R-free:
|
0.241
|
|
|
Authors:
|
 |
H.Paidassi,P.Tacnet-Delorme,V.Garlatti,C.Darnault, B.Ghebrehiwet,C.Gaboriaud,G.J.Arlaud,P.Frachet
|
|
Key ref:
|
 |
H.Païdassi
et al.
(2008).
C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition.
J Immunol,
180,
2329-2338.
PubMed id:
Ref:
|
 |
|
Date:
|
 |
|
09-Feb-07
|
Release date:
|
19-Feb-08
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
P02745
(C1QA_HUMAN) -
Complement C1q subcomponent subunit A
|
|
|
|
Seq: Struc:
|
 |
 |
 |
245 a.a.
133 a.a.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
J Immunol
180:2329-2338
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition.
|
|
H.Païdassi,
P.Tacnet-Delorme,
V.Garlatti,
C.Darnault,
B.Ghebrehiwet,
C.Gaboriaud,
G.J.Arlaud,
P.Frachet.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Efficient apoptotic cell clearance is critical for maintenance of tissue
homeostasis, and to control the immune responses mediated by phagocytes. Little
is known about the molecules that contribute "eat me" signals on the apoptotic
cell surface. C1q, the recognition unit of the C1 complex of complement, also
senses altered structures from self and is a major actor of immune tolerance.
HeLa cells were rendered apoptotic by UV-B treatment and a variety of cellular
and molecular approaches were used to investigate the nature of the target(s)
recognized by C1q. Using surface plasmon resonance, C1q binding was shown to
occur at early stages of apoptosis and to involve recognition of a cell membrane
component. C1q binding and phosphatidylserine (PS) exposure, as measured by
annexin V labeling, proceeded concomitantly, and annexin V inhibited C1q binding
in a dose-dependent manner. As shown by cosedimentation, surface plasmon
resonance, and x-ray crystallographic analyses, C1q recognized PS specifically
and avidly (K(D) = 3.7-7 x 10(-8) M), through multiple interactions between its
globular domain and the phosphoserine group of PS. Confocal microscopy revealed
that the majority of the C1q molecules were distributed in membrane patches
where they colocalized with PS. In summary, PS is one of the C1q ligands on
apoptotic cells, and C1q-PS interaction takes place at early stages of
apoptosis, in newly organized membrane patches. Given its versatile recognition
properties, these data suggest that C1q has the unique ability to sense
different markers which collectively would provide strong eat me signals,
thereby allowing efficient apoptotic cell removal.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
H.Païdassi,
P.Tacnet-Delorme,
M.Verneret,
C.Gaboriaud,
G.Houen,
K.Duus,
W.L.Ling,
G.J.Arlaud,
and
P.Frachet
(2011).
Investigations on the C1q-calreticulin-phosphatidylserine interactions yield new insights into apoptotic cell recognition.
|
| |
J Mol Biol, 408,
277-290.
|
 |
|
|
|
|
 |
A.Michlmayr,
T.Bachleitner-Hofmann,
S.Baumann,
M.Marchetti-Deschmann,
I.Rech-Weichselbraun,
C.Burghuber,
U.Pluschnig,
R.Bartsch,
A.Graf,
R.Greil,
G.Allmaier,
G.Steger,
M.Gnant,
M.Bergmann,
and
R.Oehler
(2010).
Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value.
|
| |
Br J Cancer, 103,
1201-1208.
|
 |
|
|
|
|
 |
D.A.Fraser,
K.Pisalyaput,
and
A.J.Tenner
(2010).
C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine production.
|
| |
J Neurochem, 112,
733-743.
|
 |
|
|
|
|
 |
D.Mevorach
(2010).
Clearance of dying cells and systemic lupus erythematosus: the role of C1q and the complement system.
|
| |
Apoptosis, 15,
1114-1123.
|
 |
|
|
|
|
 |
G.Tezel,
X.Yang,
C.Luo,
A.D.Kain,
D.W.Powell,
M.H.Kuehn,
and
H.J.Kaplan
(2010).
Oxidative stress and the regulation of complement activation in human glaucoma.
|
| |
Invest Ophthalmol Vis Sci, 51,
5071-5082.
|
 |
|
|
|
|
 |
J.I.Cohen,
S.Roychowdhury,
M.R.McMullen,
A.B.Stavitsky,
and
L.E.Nagy
(2010).
Complement and alcoholic liver disease: role of C1q in the pathogenesis of ethanol-induced liver injury in mice.
|
| |
Gastroenterology, 139,
664.
|
 |
|
|
|
|
 |
K.K.Hosszu,
F.Santiago-Schwarz,
E.I.Peerschke,
and
B.Ghebrehiwet
(2010).
Evidence that a C1q/C1qR system regulates monocyte-derived dendritic cell differentiation at the interface of innate and acquired immunity.
|
| |
Innate Immun, 16,
115-127.
|
 |
|
|
|
|
 |
L.A.Tan,
B.Yu,
F.C.Sim,
U.Kishore,
and
R.B.Sim
(2010).
Complement activation by phospholipids: the interplay of factor H and C1q.
|
| |
Protein Cell, 1,
1033-1049.
|
 |
|
|
|
|
 |
R.Han,
E.M.Frett,
J.R.Levy,
E.P.Rader,
J.D.Lueck,
D.Bansal,
S.A.Moore,
R.Ng,
D.Beltrán-Valero de Bernabé,
J.A.Faulkner,
and
K.P.Campbell
(2010).
Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice.
|
| |
J Clin Invest, 120,
4366-4374.
|
 |
|
|
|
|
 |
R.L.Rich,
and
D.G.Myszka
(2010).
Grading the commercial optical biosensor literature-Class of 2008: 'The Mighty Binders'.
|
| |
J Mol Recognit, 23,
1.
|
 |
|
|
|
|
 |
Y.Zhang,
H.J.Kim,
S.Yamamoto,
X.Kang,
and
X.Ma
(2010).
Regulation of interleukin-10 gene expression in macrophages engulfing apoptotic cells.
|
| |
J Interferon Cytokine Res, 30,
113-122.
|
 |
|
|
|
|
 |
A.E.Phillips,
J.Toth,
A.W.Dodds,
U.V.Girija,
C.M.Furze,
E.Pala,
R.B.Sim,
K.B.Reid,
W.J.Schwaeble,
R.Schmid,
A.H.Keeble,
and
R.Wallis
(2009).
Analogous interactions in initiating complexes of the classical and lectin pathways of complement.
|
| |
J Immunol, 182,
7708-7717.
|
 |
|
|
|
|
 |
A.P.Sjöberg,
L.A.Trouw,
and
A.M.Blom
(2009).
Complement activation and inhibition: a delicate balance.
|
| |
Trends Immunol, 30,
83-90.
|
 |
|
|
|
|
 |
B.Gullstrand,
U.Mårtensson,
G.Sturfelt,
A.A.Bengtsson,
and
L.Truedsson
(2009).
Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells.
|
| |
Clin Exp Immunol, 156,
303-311.
|
 |
|
|
|
|
 |
D.A.Fraser,
A.K.Laust,
E.L.Nelson,
and
A.J.Tenner
(2009).
C1q differentially modulates phagocytosis and cytokine responses during ingestion of apoptotic cells by human monocytes, macrophages, and dendritic cells.
|
| |
J Immunol, 183,
6175-6185.
|
 |
|
|
|
|
 |
D.Sansonno,
F.A.Tucci,
B.Ghebrehiwet,
G.Lauletta,
E.I.Peerschke,
V.Conteduca,
S.Russi,
P.Gatti,
L.Sansonno,
and
F.Dammacco
(2009).
Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damage.
|
| |
J Immunol, 183,
6013-6020.
|
 |
|
|
|
|
 |
H.Qu,
D.Ricklin,
and
J.D.Lambris
(2009).
Recent developments in low molecular weight complement inhibitors.
|
| |
Mol Immunol, 47,
185-195.
|
 |
|
|
|
|
 |
J.Tian,
Z.Xu,
J.S.Smith,
S.E.Hofherr,
M.A.Barry,
and
A.P.Byrnes
(2009).
Adenovirus activates complement by distinctly different mechanisms in vitro and in vivo: indirect complement activation by virions in vivo.
|
| |
J Virol, 83,
5648-5658.
|
 |
|
|
|
|
 |
L.Walter,
and
H.Neumann
(2009).
Role of microglia in neuronal degeneration and regeneration.
|
| |
Semin Immunopathol, 31,
513-525.
|
 |
|
|
|
|
 |
M.Harboe,
and
T.E.Mollnes
(2008).
The alternative complement pathway revisited.
|
| |
J Cell Mol Med, 12,
1074-1084.
|
 |
|
|
|
|
 |
P.Jeannin,
S.Jaillon,
and
Y.Delneste
(2008).
Pattern recognition receptors in the immune response against dying cells.
|
| |
Curr Opin Immunol, 20,
530-537.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
| |